B. SALLE:J. SENTERRE~G. PUTET: J. ~l G~* ( l n t r o d by A. During the last trimester of pregnuncy, the fetal sheletul growth requires a massive n~inernl transfer from mother to fetus. Inte~.rupPion of this process favors the development of osteopeniu in 1' 1. IVe studied in 1 2 PI (DW : 1318 g f 1 4 2 ; G A : 30.5 wks i 1.5), 6 fed either llRl or LDWF, fat absorption and Ca and hlg absorption and retention a t 20-25 days (study 1) and 44-45 days (study 11) after birth. Ilk1 was enriched 111 phosphate (9 mg/dl) and babies received 1500 1 In an attempt to better understand the control of plasma 1,25-(OH)2~ concentrations cbring puherty, these concentrations have been measured i n 12 g i r l s (age 3 yr 6 no-8 yr 10 mo) w i t h central precocims puherty hefore and after 3, 6, 9, 12, 18 and 24 months of treatment with a LHRH analowe (Fluserelina, Hoechst). Mean and extreme values for 1,25-(OH)2~ were 76 pg/ml (53-114) before treatment, 68 pg/ml (43-107) and 45 pg/ml (26-87) after 12 and 18-24 months of treatment respectively. No correlation was f d a t any time studied between plasma 1,25-(OH)2~ and : plasma estradiol, plasm DHAS, vaginal maturation index, hone age,hei&t gain (cm/year), plasma SmC/IGFI, serum calcium, phosphorus and alkaline phosphatase activity. Plasma 1,25(OH)2~ values were also not correlated with plasma basal LH and FSH hefore treatment, but were significantly correlated with plasma hasal LH ( r : 0.67, $0.02) and plasma basal FSH ( r m 0.71, p<0.01) after 12 months of treatment. ilTHfm1/1) 4 6 9 6
These results showed : 1) Fat, Ca and hlg absorption were low in 1' 1 fed lfhl but increased with postnatal age. 2) In PI fed I.II\VF, fut absorption was normal, Ca and hlg retention was higher in both studies. 2501iD(RIA) , ? , 2 5 k ( W ) ,DBP(radial imunodiffusion) and alkaline phosphatase(AP) were measured i n serum a t bodyweights 1800+75g(I) and 2150+75g(II) ,respectively.Results were not significantiy-diff e r e n t K t h i n p a i r s and therefore a r e indicated together a s x+SD: 175 H.Garah6dian*,R.RraunerX,R.Grimher~,C.Pr6vot*,R.Rappaport, In an attempt to better understand the control of plasma 1,25-(OH)2~ concentrations cbring puherty, these concentrations have been measured i n 12 g i r l s (age 3 yr 6 no-8 yr 10 mo) w i t h central precocims puherty hefore and after 3, 6, 9, 12, 18 and 24 months of treatment with a LHRH analowe (Fluserelina, Hoechst). Mean and extreme values for 1,25-(OH)2~ were 76 pg/ml (53-114) before treatment, 68 pg/ml (43-107) and 45 pg/ml (26-87) after 12 and 18-24 months of treatment respectively. No correlation was f d a t any time studied between plasma 1,25-(OH)2~ and : plasma estradiol, plasm DHAS, vaginal maturation index, hone age,hei&t gain (cm/year), plasma SmC/IGFI, serum calcium, phosphorus and alkaline phosphatase activity. Plasma 1,25(OH)2~ values were also not correlated with plasma basal LH and FSH hefore treatment, but were significantly correlated with plasma hasal LH ( r : 0.67, $0.02) and plasma basal FSH ( r m 0.71, p<0.01) after 12 months of treatment. ilTHfm1/1) 4 6 9 6
Frm these results, m e may speculate that the control of plasma 1,25-(OH)2~ &ring puherty i s not directly dependent upon skeletal grauth, skeletal maturation and ovarian secretion but could he, a t least partially, dependent upon central factors. The syndrome of 1,25(OH)$J r e s i s t a n t r i c k e t s and alopecia has been shown t o be caused 2 ; defective receotors t o the a c t i v e D-metabolite (ESPE, 1982; JCEM 55:1020 JCEM 55: , 1982 . In search of a therapeutic approach, 7 pa l e n t s aged 2-12 years were treated.
' .
On a megadose of 60 uq/m /day of l a O H D f o r P months, serum 1,25(OH) 0 increased t o 1100-3000 pg/ml (normal, 20-80 pg/ml), but ric$e$s was not healed.
Treatment of 3 p a t i e n t s with 20 ug/m2/day of 24,25(0Hf2n3.with serum 24,25(0H)2D3 of 6.2-14 n4/ml (normal 1.5-4 ng/ml) f a i l e d t o heal $he r i c k e t s . With combined treatment of 24,25(OH)2D3 ?nd 30 mg/m /day i.v. calcium, rickets was not healed.
Two children, 6 and 3 years old, received 70 mg/m2/day elementary calcium through an intracaval c a t h e t e r , and serum calcium was maintained a t 21.1.-10 mg/dl. Bone pains and muscular weakness disappeared within a week.
Serum PTH and phosphatase normalized a f t e r I and 4 months, respectively. X-rays dewonstrated complete healing of the r a c h i t i c bone changes a f t e r 4 and 6 months, respectively, and the c h i l d r e n ' s qrowth accelerated t o 16.5 and 9.8 cmlyear, respectively. These observations indicate t h a t normalization of serum calcium i s s u f f i c i e n t f o r healing of rickets and growth, even in t h e absence of functioning 1 ,25 (0H) AP was normal i n a l l samples. Both 1 ,25Dc and FDI were high when compared t o adult reference values but occurrcd without hypophosphatemia o r hyperparathyroidism. The significance of high t o t a l and f r e e 1,25Dc i n pren~aturc inf a n t s and the mechanisms of i t s regulation remain t o be clucidated.
6,7+0,4 8,8+2,6 125I:c @ptQ 7 5~2 8 I IJO i s a rare condition of osteoporosis in childhood. The disease requires rapid growth t o be c l i n i c a l l y manifest and i t occurs in adolescence or in early childhood. The pathogenesis i s unknow. W e examined 3 boys (FM, 2.3 yrs; DBM, 12.1 y r s , TM, 11.5 y r s ) and 1 g i r l (GR, 12.6 y r s ) with IJO. Ca, P, M g were in Three p a t i e n t s with r i c k e t s t h a t appeared a t 1 t o 2 years old and alopecia t h a t appeared a t 2 t o 4 months old were diagnosed a t 2 t o 3 years old as having vitamin D-dependent r i c k e t s type I1 (VDDR I I ) , because of hypocalcemia, hyperparathyroidism, and increased plasma l e v e l s of alkaline phosphatase and 1,25-dihydroxyvitamin D [1,25-(03) D 1. Inpaired nuclear uptake and normal cytosol binding of [ ~7 1 ? 2 5 -( 0~) D were observed i n cultured skin f i b r o b l a s t s and PHA-stimu?a?ed phocytes of these patients. In addition, t h e incorporation of 'q-thymidine i n t o PHA-stimulated lymphocytes of t h e patients was not reduced by 1,25-(OH) D unlike i n control lymphocytes. These ga4;ent.s were t r e a t e d with la-hydroxyvitamin D [la-OHD 1 and calcium(Ca) l a c t a t e . Two p a t i e n t s responded t o 3 u&kg/day3 of la-OHD and 2 g/day of Ca l a c t a t e , and t h e i r blood chemistry and bone 3esions were normalized a f t e r 15 and 36 weeks of treatment. However, the most severe case responded only p a r t i a l l y t o 5 ug/kg/day of la-OHD and 2 g/day of Ca l a c t a t e . The alopecia of the p a t i e n t s was nat improved by these treatments. These r e s u l t s suggest t h a t high doses of la-OHD may be useful i n treatment of MDR I1 with alooecia, which ha& been reported
